Effect of Treatment of Cystic Fibrosis Pulmonary Exacerbations on Systemic Inflammation

Abstract

Circulating inflammatory proteins demonstrate and predict a response to treatment of CF pulmonary exacerbations. A systemic biomarker panel could speed up drug discovery, leading to a quicker, more efficient drug development process for the CF community.